Post-COVID-19 Cardiovascular Sequelae and Myocarditis

Lakshmi Chakradhar Yarlagadda1, Debasish Ghosh2, Ullash Basak1

  • 1Intern Doctor, GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh.

Insights

Post-COVID-19 cardiovascular issues, including myocarditis and myocardial infarctions, are significant public health concerns. This review details acute and chronic cardiac manifestations and management strategies for coronavirus disease 2019 (COVID-19).

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiovascular (CV) complications, including myocarditis and myocardial infarctions (MIs), are significant public health issues following coronavirus disease 2019 (COVID-19).
  • This review synthesizes current knowledge on acute and chronic cardiac manifestations associated with COVID-19.

Approach:

  • A comprehensive literature search was conducted across multiple electronic databases from 2020 to 2022.
  • Seventy-three articles detailing COVID-19 and its cardiac manifestations were identified and analyzed.

Key Points:

  • Cardiometabolic risk factors play a crucial role in exacerbating COVID-19 severity.
  • The review covers cardiac pathology, mechanisms of CV consequences in acute COVID-19, and microvascular injury.
  • It also addresses chronic CV disease linked with COVID-19 and therapeutic drug effects on the heart.

Conclusions:

  • Understanding the cardiac pathology and consequences of COVID-19 is vital for clinical practice.
  • Investigational approaches and management strategies for post-COVID-19 cardiovascular sequelae are discussed.
  • Prioritizing cardiometabolic risk factors is essential for managing COVID-19 patients.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14